Loading provider…
Loading provider…
Internal Medicine Physician in Gillette, WY
NPI: 1093785735Primary Practice Location
CAMPBELL COUNTY HEALTH
501 S Burma Ave, Gillette, WY
Primary Employer
Health Concepts
rchealthconcepts.com
HQ Phone
Get MD Richard's Phone NumberMobile
Get MD Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 194 | 387 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 159 | 293 |
| 3 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 135 | 135 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 115 | 198 |
| 5 | G0008Administration of influenza virus vaccine | 79 | 79 |
Authors: Richard Davey, John Beigel, Horace Holley, Melanie Hoppers
Journal: Clin Infect Dis
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Authors: Richard Davey, John Beigel, Horace Holley, Alex Slandzicki
Publication Date: 2017-05-22
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Engensis
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Engensis
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Placebo, DRUG: Oseltamivir